izvor podataka: crosbi
✓
PCSK9 inhibitors - past, present and future (CROSBI ID 233002)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Reiner, Željko
PCSK9 inhibitors - past, present and future // Expert opinion on drug metabolism & toxicology, 11 (2015), 10; 1517-1521. doi: 10.1517/17425255.2015.1075506
Podaci o odgovornosti
Reiner, Željko
engleski
PCSK9 inhibitors - past, present and future
Lowering low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular disease (CVD) morbidity and mortality. Statins are the treatment of choice for lowering LDL-C but a considerable number of patients treated with statins are unable to achieve LDL-C target and many are statin-intolerant.
alirocumab ; bococizumab ; cardiovascular disease prevention ; evolucumab
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
11 (10)
2015.
1517-1521
objavljeno
1742-5255
10.1517/17425255.2015.1075506
Povezanost rada
Temeljne medicinske znanosti
Poveznice
Indeksiranost
